{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-032979","form_type":"8-K","ticker":"CGTX","cik":"0001455365","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2024-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.234564+00:00","generated_at":"2026-06-04T23:45:17.608106+00:00","sec_items":["2.02"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cognition Therapeutics reports preliminary FY2023 net loss of $25.6M; cash at $29.9M","bullets":["Preliminary net loss for FY2023 expected to be approximately $25.6 million.","Cash and cash equivalents as of Dec 31, 2023: $29.9 million.","Results are unaudited and subject to revision upon completion of audit.","No revenue reported; company is a clinical-stage biotech."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-032979","json":"https://secwatch.observer/filing/0001104659-24-032979.json","markdown":"https://secwatch.observer/filing/0001104659-24-032979.md","text":"https://secwatch.observer/filing/0001104659-24-032979.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924032979/0001104659-24-032979-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924032979/tm248362d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T23:45:17.608106+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e0702209863962c9f55bd9164b428a3dc080e288","claim":"COGNITION THERAPEUTICS INC reported the year ended December 31, 2023 results: net income approximately $25.6 million.","evidence_excerpt":"Preliminary unaudited consolidated operating results for the year ended December 31, 2023 and certain preliminary financial condition information as of December 31, 2023 are as follows: · Net loss for the year ended December 31, 2023 is expected to be approximately $25.6 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924032979/0001104659-24-032979-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2023"},{"label":"Net income","value":"approximately $25.6 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}